European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine

PRODUCT LITERATURE

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine

Deligianni CL - Personal Name;

Novel disease‑specific and mechanism‑based treatments sharing good evidence of efficacy for migraine have been recently marketed. However, reimbursement by insurers depends on treatment failure with classic anti‑migraine drugs. In this systematic review and meta‑analysis, we aimed to identify and rate the evidence for efficacy of flunarizine, a repurposed, first‑ or second‑line treatment for migraine prophylaxis.

Availability

Location name is not set Location name is not set

Degrium-003

Available

Detail Information

Series Title: -
Call Number: -
Publisher: : .,
Collation: -
Language: English
ISBN/ISSN: -
Classification: NONE
Content Type: LITERATURE
Media Type: -
Carrier Type: -
Edition: -
Subject(s): Degrium
Flunarizine
Migraine
Specific Detail Info: -
Statement of Responsibility: The Journal of Headache and Pain (2023) 24:128

Other version/related

No other version available

File Attachment

Read Here

Comments

You must be logged in to post a comment